IRB Regulation Anti-Doping
De Redactia Rugby , 01 Mar. 2004
Updated April 2004
REGULATION 21. ANTI-DOPING
21.1 Doping
21.1.1 Doping is strictly forbidden and constitutes a Doping Offence under Board
Regulations. Doping occurs when:
a) a Prohibited Substance or its Metabolites or Markers are found to be present in a Person’s body tissue or fluids; or
b) a Person uses or attempts to use or there is evidence of use or takes advantage of a Prohibited Method; or
c) a Person admits orally or in writing having used or taken advantage of a Prohibited Substance or Prohibited Method, or is found to have used a Prohibited Substance or Prohibited Method; or
d) a Person uses an artifice, whether a substance or method, potentially dangerous to a Person’s health and/or capable of enhancing their performance.
21.1.2 A Person who fails or refuses to provide a sample for a drug test or who fails or refuses to comply with any provision of this Regulation, or who otherwise seeks to avoid a drug test having been requested to do so by an authorised official, shall have committed a Doping Offence.
21.1.3 Any Person trading, trafficking, distributing, supplying, administering or selling (or attempting any of the same) any Prohibited Substance or Prohibited Method, or who is in possession of a Prohibited Substance or Prohibited Method, other than in the course of the proper and legal exercise of a recognised profession or trade, shall have committed a Doping Offence.
21.1.4 Any Person who obstructs or interferes or undermines or attempts to obstruct or interfere or undermine the conduct of a drug test or the carrying out of these Regulations shall have committed a Doping Offence.
21.1.5 Any Person who procures, induces, counsels, assists, abets, covers up or incites (or who attempts to do any of the same) the use of a Prohibited Substance or Prohibited Method, or the commission of any other Doping Offence, shall have committed a Doping Offence.
21.1.6 The failure by a Person to notify the Anti-Doping Manager, tournament organiser or Secretary of the Union (as the case may be) of the Declaration of Medication in accordance with Regulation 21.7.1 shall constitute a Doping Offence and may render a Person liable to sanctions.
21.1.7 A Player who fails to make themself available or fails to provide appropriate information for Out-of-competition testing in accordance with the Board policy or the policy of other relevant authorities (as appropriate) shall have committed a Doping Offence.
21.2 Prohibited Substances and Prohibited Methods
For the purposes of this Regulation Prohibited Substances and Prohibited Methods shall mean those substances and methods included in the WADA Prohibited List (subject to any Board modifications from time to time in force) and includes any Related Substance. Related Substance means any substance having pharmacological action and/or chemical structure similar to a Prohibited Substance or any substance referred to in these Regulations/the WADA Prohibited List.
21.2.2 The WADA Prohibited List appears at Schedule 2 of this Regulation. The List shall be updated by WADA from time to time and any such revision shall be automatically effective from the date the revised WADA Prohibited List comes into force.
21.2.3 The expression Prohibited Substance shall include a Metabolite characteristic of a Prohibited Substance, and/or its Marker and/or Related Substances.
21.3 Strict Liability
21.3.1 A Person is absolutely responsible for any Prohibited Substance found to be present in his body. Accordingly, it is not necessary that intent or fault or knowledge on the Person’s part be shown in order for a Doping Offence to be established. Nor is lack of intent or fault or knowledge a defense to a Doping Offence.
21.4 Personal Responsibility
21.4.1 It is each Person’s responsibility to ensure that no Prohibited Substance is found to be present in his body and that Prohibited Methods are not used. A Person is responsible for any Prohibited Substance detected in samples provided by him. It is also the personal responsibility of each Person to ensure that he does not commit any other Doping Offence.
21.4.2.1 The success or failure of the use of a Prohibited Substance or Prohibited Method in any particular case is not relevant.
21.4.2.2 Persons, including Minors, are deemed to accept the IRB Anti-Doping Regulations by virtue of their participation in rugby union.
21.4.3 It is the sole responsibility of each Person to acquaint himself with all of the provisions of these Anti-Doping Regulations including the Guidelines. It is also each Person’s sole responsibility to notify other relevant persons, including, but not limited to, their doctors of their obligation not to use Prohibited Substances and Prohibited Methods and to ensure that any medical treatment received by them does not violate any of the provisions of this Regulation.
21.4.4 Many of the substances in the WADA Prohibited List may appear either alone or as part of a mixture within medications or supplements which may be available with or without a doctor’s prescription. Any Person who is concerned about the appropriateness of treatment being administered to him, or medications or supplements being ingested by him, should seek clarification from his doctor or other relevant authority as to whether such treatment is or such medications are prohibited.
21.5 Anti-Doping Advisory Committee and Guidelines
21.5.1 The Board shall appoint an Anti-Doping Advisory Committee to provide the Board with general advice and assistance on doping issues and related matters, including the application of Anti-Doping Regulations. The Anti-Doping Advisory Committee shall report to the Council.
21.5.2 In addition to this general role, the Anti-Doping Advisory Committee, or a member or members thereof may be requested to undertake specific tasks as part of the implementation of the IRB Anti-Doping Regulations. Procedural Guidelines (“Guidelines”) for the conduct of drug tests shall be determined by the Anti-Doping Advisory Committee from time to time.
21.5.3 The Anti-Doping Advisory Committee and/or the Board shall be entitled to call on experts to provide specialist advice, undertake certain activities and assist in the implementation of the Regulations including but not limited to acting on the Anti-Doping Advisory Committee Review Boards.
21.6 Requirements to Undergo a Drug Test
21.6.1 A drug test may be carried out at any time. Drug tests may be random or specific. All Persons shall submit to a drug test at any time and any place whenever requested by an authorised official. For the avoidance of doubt, this includes both In-competition and Out-of-competition drug testing. Out-ofcompetition testing may be undertaken with or without prior notice. A Person may be selected to provide any number of samples for drug tests in any calendar year.
21.6.2 A drug test may only be conducted on a Minor where prior written consent has been given by a person with legal responsibility for that Minor.
21.6.3 Procedural Guidelines for the conduct of In-competition and Out-of-competition drug tests are set out in the Guidelines in Schedule 1 of this Regulation.
21.7 Declaration of Medication
In accordance with the WADA Prohibited List, any Player who needs to use, for medical purposes any of the Prohibited Substances set out below in International Matches must notify, in writing, the Anti Doping Manager of the IRB or tournament organiser (as the case may be) annually or in accordance with the IRB Declaration of Medication Form at least 48 hours prior to the International Match taking place. This declaration shall be made on the IRB Declaration of Medication Form attached at Schedule 3 and be signed by the Player and his prescribing physician and/or respiratory physician and/or endocrinologist as appropriate.
For all other Matches Players must notify in writing the CEO or Secretary of the Union of which they are a member if they use any of the Prohibited Substances set out below for medical purposes, annually or in accordance with the IRB Declaration of Medication Form at least 48 hours prior to the Match taking place and utilise the IRB Declaration of Medication Form or provide a valid medical certificate from their prescribing physician and/or respiratory physician and/or endocrinologist as appropriate.
a) Beta 2 Agonists (formoterol, salbutamol, salmeterol and terbutaline) by inhaler only to prevent and/or treat asthma and exercise-induced asthma.
b) Glucorticosteroids administered by non systemic routes such as local or intra articular injections, topical, anal, aural, ophthalmic and inhalation. Written notification from a respiratory physician or the Player’s prescribing physician is necessary.
21.8 In-Competition and Out-of-competition Drug Testing
21.8.1 Each Union must include within its regulations the following provisions: a) a provision that entitles the Union to conduct both In-competition and Out-ofcompetition drug tests;
b) a provision allowing the Board to conduct Out-of-competition drug tests on Persons within or under that Union’s jurisdiction; and
c) a provision allowing the Board to conduct drug tests on Persons at Matches that form part of a Union’s national competitions or similar events.
21.8.2 Each Union shall make it a condition of membership and a condition of participation in their competitions that their members agree to be subject to Incompetition and Out-of-competition drug testing by both the Union and the Board.
21.8.3 The nature of Out-of-competition drug testing makes it desirable that little or no prior warning is given to the Person being tested. When an Out-of-competition drug test is undertaken reasonable efforts will be made to avoid interruption to a Person’s training and/or social plans, however, neither the Board, or its designees, shall be liable for any inconvenience or loss resulting from Out-ofcompetition drug testing.
21.8.4 It is the duty of each Union to assist the Board and, where applicable, other Unions in undertaking drug tests. Any Union preventing, hindering or otherwise obstructing the carrying out of such testing shall be subject to disciplinary action by the Board. Any Rugby Body or Club that prevents, hinders or otherwise obstructs the carrying out of any drug test shall be subject to disciplinary action by their Union.
21.8.5 Without prejudice to the requirement on Unions to notify all Doping Offences in accordance with the provisions of Regulation 21.12.7 each Union must submit a report of all drug tests undertaken and a summary of the results of those drug tests annually to the Board.
21.8.6 Each Union is responsible for ensuring in relation to its own anti-doping programme and the implementation of the IRB Anti-Doping Regulations that any and all applicable data regulation clearances and medical confidentiality clearances are obtained.
21.9 Substances tested
21.9.1 Out-of-competition drug tests shall be conducted only in respect of anabolic agents, peptide hormones, agents with anti-oestrogenic activity, masking agents, Beta 2 Agonists (only clenbuterol, and salbutamol when its concentration in urine is greater than 1000ng/mL) and Prohibited Methods and other substances as determined by WADA for monitoring purposes.
21.9.2 In-competition drug tests shall be analysed in respect of anabolic agents, stimulants, narcotics, peptide hormones, and agents with anti-oestrogenic activity, masking agents, Beta 2 Agonists, Cannabinoids and Glucocorticosteroids and Prohibited Methods and other substances as determined by WADA for monitoring purposes.
21.10 Suspension & Retirement
21.10.1 Where a Person has been suspended, other than for life, and wishes to resume competing after his period of suspension has expired, he must make himself available for Out-of-competition drug testing during that period of suspension. If a Person commits a Doping Offence during the course of a suspension the matter shall be treated as a separate Doping Offence.
21.10.2 A Person who retires as a playing member of his Union shall notify his Union of such retirement in writing. For a period of 12 months following written notification of retirement a Person remains eligible to be drug tested Out-ofcompetition.
21.10.3 A Person who has retired, but who wishes to resume playing, should submit to drug testing for a period of 3 months before being deemed eligible by any Union to participate as a Player.
21.11 Responsibility for Doping Control
21.11.1 The Board is responsible for conducting or arranging drug tests including, but not limited to, sample collection, result management, the conduct of investigations and disciplinary proceedings and the imposition of sanctions for Doping Offences, including cases where there has been no drug test carried out, in respect of: Rugby World Cup Qualifying and Finals Tournaments; Rugby World Cup Sevens Tournaments; IRB Sevens Series Women’s Rugby World Cup Qualifying and Finals Tournaments; Under 21’s World Championship Under 19’s World Championship Such other Matches or tournaments as the Board shall from time to time determine; Such other occasions where the Board conducts Out-of-competition drug tests.
21.11.2 Modified and/or additional procedures and rules to those set out in this Regulation 21 may be adopted by the Board and/or tournament organiser designated by the Board.
21.11.3 Subject to Regulation 21.11.4 below, in all other cases (except where drug tests are carried out under the rules of another sporting body) the Union conducting or arranging the drug test, or in whose jurisdiction a Match is held, will be responsible for the conduct of the drug tests, result management, the conduct of investigations and disciplinary proceedings and the imposition of sanctions for Doping Offences.
21.11.4 Responsibility for conducting or arranging drug tests including, but not limited to, sample collection, result management, the conduct of investigations and disciplinary proceedings and the imposition of sanctions for Doping Offences, including cases where there has been no drug test carried out, in respect of:
a) International Matches;
b) International Tours;
When a Doping Offence Arises
c) International Tournaments (save as set out in Regulation 21.11.1 and 21.11.2 above); or
d) other tournaments, may, subject to the prior written approval of the Board, compliance with the Board’s Anti-Doping Regulations and Guidelines, and the consent of the Unions concerned be delegated to the Host Union, International tournament organiser or other tournament organisers (as the case may be).
21.12 The Role of Unions Implementing the Anti-Doping Regulations
21.12.1 Each Union must have in place appropriate Anti-Doping Regulations governing the use of drugs and other Doping Offences and imposing Board prescribed sanctions where a Doping Offence has been found to have been committed.
21.12.2 Individual Unions are required to implement and apply the Board’s Anti-Doping Regulations and the recommended procedures set out in the Guidelines, save to the extent that a Union’s regulations need to be varied to take into account the requirements of governmental anti-doping legislation and national drug testing authorities and/or as otherwise provided in this Regulation 21.
21.12.3 The Board will inform every Union if, in the best interests of the Game, procedures and sanctions other than or in addition to those contained in this Regulation and/or the Guidelines are to be introduced or withdrawn.
21.12.4 Each Union must ensure, (and is responsible for ensuring), that it takes appropriate action to inform each and every one of its members of these Anti- Doping Regulations and the Union’s anti-doping regulations. Unions must further inform their members that they must comply with the Board’s Anti- Doping Regulations and the anti-doping regulations of the Union under whose jurisdiction they are participating.
21.12.5 Where a Doping Offence arises out of a drug test conducted or arranged by a Union, or a Union believes or becomes aware that another Doping Offence may have been committed by one of its members or a Person under its jurisdiction, that Union shall deal with the matter in accordance with its own anti-doping procedures.
21.12.6 As a minimum requirement, each Person alleged to have committed a Doping Offence shall have the right to a hearing before a suitably qualified disciplinary body established by his Union before a final decision is reached unless that Person waives that right. The disciplinary body should consist of not less than three individuals, one of whom shall have knowledge of drug testing procedures and the Olympic Movement Anti-Doping Code. The disciplinary body shall deal with the matter in accordance with the national law and the regulations of the Union.
21.12.7 When a Union or tournament organiser (as the case may be) receives a report that the analysis of a Person’s “A” sample discloses the presence of a Prohibited Substance or where a Union or tournament organiser believes, or becomes aware, that a Doping Offence may have been committed, that Union or tournament organiser must notify the CEO of the Board immediately. The
21.13.2 Not withstanding the provisions of Regulation 21.13 Persons under investigation for an alleged Doping Offence by the Board, a Union or tournament organiser shall not be allowed to participate in any IRB competitions pending the outcome of such investigation and the resolution of the case.
21.13.3 CEO shall be entitled to receive from a Union or tournament organiser such additional information as he may consider necessary in relation to any alleged Doping Offence. In any event, in accordance with Regulation 21.22.2 the CEO is entitled to receive from and shall be provided with a full report of all hearings in respect of Doping Offences by the relevant Union or tournament organiser (as the case may be) within 14 days of a final decision having been made.
21.12.8 Subject to Regulations 21.11.3 and 21.11.4, where the conduct of a drug test results in a positive test or other Doping Offence or where a Doping Offence arises other than through the conduct of a drug test in respect of a Person who is not a member of the Union that conducted or was responsible for arranging the test, then that Union shall report the results of such tests to the Union that normally exercises jurisdiction over such Person. The Person may elect to have his own Union conduct the appropriate investigation and hearing procedures (and where a Doping Offence is found to have been committed, impose the applicable sanctions) if, and only if:
(a) in the case where there has been a positive test, the Person acknowledges in writing, that no issue will be taken at the hearing as to the:
i) qualifications or authority of any official of any drug testing/collection agency or WADA Accredited Laboratory;
ii) sample collection procedures;
iii) custody or transmission of any sample; and
iv) analysis of any sample by a testing agency or WADA Accredited Laboratory.
(b) in all other cases, the Person acknowledges in writing his election to refer the matter back to his own Union.
21.12.9 Where a Person elects to have his own Union conduct the appropriate investigation and hearing under Regulation 21.12.8, such election by a Person must be confirmed to his Union within 14 days of being notified of the positive test result and/or the alleged Doping Offence. The Person’s own Union must notify the visited Union of any such election. If a person does not elect to have the hearing procedures carried out by his own Union, then the visited Union where the drug test was conducted shall have jurisdiction and shall conduct the investigation and hearing procedures (and where a Doping Offence is found to have been committed, impose the applicable sanctions).
Investigations
The Board or its designee may carry out investigations into the activities of any Person, Union, Association, Rugby Body or Club who it has reasonable cause to believe may have committed a Doping Offence. Any such Person, Union, Association, Rugby Body or Club shall co-operate with any such Board investigation.
Where the Board or its designee undertakes an investigation into an alleged Doping Offence (which does not involve the provision of a sample) the following procedures shall apply, subject to such modifications as the Board may consider necessary in accordance with the facts and circumstances of the particular case:
Any investigation shall be carried out as soon as reasonably practicable after the Board becomes aware of the alleged Doping Offence.
The Board or its designee may request that additional information be provided.
The Board or its designee shall determine whether they believe that a Doping Offence may have been committed.
Where it is decided that there are no grounds to conclude that a Doping Offence may have been committed no further action will be taken and any provisional suspension shall be automatically lifted.
Where it is determined that a Doping Offence may have been committed by a Person, the Board shall notify the Person concerned and/or his Union. The procedures set out in Regulation 21.16 below shall apply in respect of any provisional suspension of the Person concerned. In addition the Person and his Union shall be notified in accordance with Regulation 21.17.11 that the matter shall be referred to a Board Judicial Committee and the procedures set out in Regulation 21.18 shall apply.
21.14 Confidentiality
21.14.1 Where a Doping Offence may have been committed, the Board and the Union or tournament organiser concerned shall take reasonable steps to maintain confidentiality until the testing and analysis has been completed, the Judicial Committee hearing decision has been reached and the Person and his Union have been informed.
21.15 Authorised Doping Control Bodies
21.15.1 The Board, Union or tournament organiser (as the case may be) may appoint a doping control / governmental agency or any other third party that they deem suitable to collect samples.
21.15.2 All samples collected, whether by or for the Board, Union, tournament organiser or any other third party shall be analysed at a WADA Accredited Laboratory.
21.15.3 All samples collected by the Board or its designee, and the results of the analysis of such samples, shall remain the property of the Board.
21.16 Provisional Suspension
21.16.1 When the Board, Union or tournament organiser (as the case may be) receives a report that the analysis of a Person’s “A” sample discloses the presence of a Prohibited Substance or use of a Prohibited Method or when the Board, Union or tournament organiser believes or becomes aware that a Doping Offence whether or not it involves the provision of a sample, may have been committed, that Person shall subject to Regulations 21.17.1 and 21.17.2, in the case of a positive “A” sample and subject to Regulation 21.13.3, in the case where there is no sample, be provisionally suspended by the Board, tournament organiser and/or his Union pending the resolution of the case.
“A” Sample Analysis
21.17.4 A Person may accept the results of the “A” sample analysis by advising the Board (or his Union) within 14 days of receiving notification that the “A” sample analysis discloses the presence of a Prohibited Substance. Notwithstanding such acceptance, the Board may still, at its discretion, make arrangements to have the “B” sample analysed. The person concerned shall be informed of his entitlement to a hearing before a Board Judicial Committee.
21.17.6 Where the “A” sample denotes the presence of a testosterone (T) to epitestosterone (E) ratio greater than six (6) to one (1) in the urine of a Person, this constitutes a Doping Offence unless there is evidence that this ratio is due to a physiological or pathological condition (for example, low epitestosterone excretion, androgen production by tumour, enzyme deficiencies). In the case of T/E greater than 6, an investigation must be undertaken before the sample is declared positive. A report will be written by the responsible authority and will include a review of previous tests, subsequent tests and any results of endocrine investigations. In the event that previous tests are not available, the Person should be tested unannounced at least once per month for three months. The results of these investigations should be included in the report. Pending the preparation of the
21.17 Due Process
The procedure set out in Regulation 21.17 below may be varied in respect of the IRB designated events.
Positive Sample
21.17.1 When the Board receive a report that the analysis of a Person’s “A” sample discloses the presence of a Prohibited Substance, or use of a Prohibited Method the Board, shall arrange for a preliminary review of the case to be undertaken by a representative or representatives of the Board’s Anti-Doping Advisory Committee to establish if, pursuant to Regulation 21.7.1, there is a Declaration of Medication on the Person’s file that explains the positive test result or if procedural irregularities exist that materially affect the validity of the test. Such preliminary review shall, ordinarily, be completed within 3 days.
21.17.2 If, following such preliminary review, it is decided that a Doping Offence may have been committed, the Board shall notify the Person concerned and/or his Union. The procedures set out in Regulation 21.16.1 above shall apply in respect of any provisional suspension of the Person concerned.
21.17.3 Every Person whose “A” sample discloses the presence of a Prohibited Substance or use of a Prohibited Method shall have the right to request that his “B” sample be analysed to determine whether that sample discloses the same Prohibited Substance(s) or use of a Prohibited Method detected in the main “A” sample. Any such request must be made within 14 days of the notification to the Person that his main “A” sample discloses the presence of a Prohibited Substance or use of a Prohibited Method. Where applicable, arrangements for the analysis of the “B” sample shall be made as soon as reasonably practicable.
21.17.5 A Person who has neither accepted the results of the “A” sample analysis, nor requested that his “B” sample be analysed within 21 days of receiving notification that his “A” sample disclosed the presence of a Prohibited Substance or use of a Prohibited Method, shall be deemed to have accepted the results of the “A” sample analysis. The Person concerned shall be informed of his entitlement to a hearing before a Board Judicial Committee. report, a Person shall not be deemed to have committed a Doping Offence and shall be entitled to continue playing the Game. However, a failure by a Person to co-operate in the investigations will result in declaring the sample positive.
“B” Sample Analysis
21.17.7 If a Person requests that his “B” sample be analysed it shall be at his own expense.
21.17.8 At any “B” sample analysis, the Person whose sample is being analysed and/or his representative are entitled to be present at their own expense. A representative of the Person’s Union and the Board may also be present. The Person whose sample is being analysed may request that the “B” sample be analysed at a different WADA Accredited Laboratory. Transfer costs of the sample will be at the Person’s own expense.
21.17.9 If the “B” sample analysis does not disclose the presence of a Prohibited Substance or use of a Prohibited Method the entire test shall be considered negative. The Person who provided the sample and/or his Union shall be notified and no further action will be taken. Any provisional suspension imposed shall be lifted.
21.17.10 Where the “B” sample analysis discloses the presence of a Prohibited Substance or use of a Prohibited Method, the Person concerned and his Union shall be notified. The Person shall be informed of his entitlement to a hearing before a Board Judicial Committee.
Hearing Procedures
21.17.11 If a Person, having been notified of his entitlement to a hearing before a Board Judicial Committee, does not request a hearing within 14 days of being so notified then that Person shall be deemed to have waived his right to a hearing and shall be deemed to have accepted that he has committed a Doping Offence. The person shall then be subject to the prescribed sanction under Regulation 21.19.
21.17.12 Where the matter is referred to a Board Judicial Committee the Person concerned shall:
a) be notified that the matter has been referred to a Board Judicial Committee;
b) be provided with relevant reports and documentation in relation to the Doping Offence (including the WADA Accredited Laboratory documentation where applicable); and
c) be invited, together with any legal representative he may wish to appoint, to attend a hearing before the Board Judicial Committee to present relevant material and submissions.
21.17.13 The hearing before the Board Judicial Committee shall be held without unnecessary delay and shall be expedited where the circumstances warrant it.
21.18 Judicial Committees dealing with Doping Offences
21.18.1 A Board Judicial Committee appointed to hear cases involving Doping Offences shall ordinarily comprise three (3) members:
a) A senior legal practitioner who shall act as Chairman; and
c) allow the remaining members of the Judicial Committee to hear the appeal.
b) An experienced medical practitioner with knowledge of doping in sport and the Olympic Movement Anti Doping Code; and
c) Either a second person from category (a) or (b) above or an ex-player or Rugby Football administrator with relevant knowledge and experience.
21.18.2 If a Member of the Judicial Committee is unable or unwilling, for whatever reason, to hear the case, then the Board may, at its absolute discretion:
a) appoint a replacement; or
b) appoint a new Judicial Committee; or
21.18.3 Judicial Committees shall be entitled to call on experts to provide specialist advice, including legal advice.
21.18.4 Judicial Committees may request that an IRB representative attend and present information in relation to the Doping Offence.
21.18.5 IOC Accredited Laboratories are presumed to have conducted testing and custodial procedures in accordance with prevailing and acceptable standards of scientific practice. This presumption can be rebutted by convincing evidence to the contrary, but the WADA Accredited Laboratory shall have no onus in the first instance to show that it conducted the procedure other than in accordance with its customary practices.
21.18.6 Judicial Committees when considering cases involving Doping Offences shall have to satisfy themselves that on the balance of probabilities a Doping Offence has been committed.
21.18.7 The decision of the Judicial Committee shall be advised to all parties as soon as practicable after the conclusion of the hearing. When it considers it appropriate, the Judicial Committee may deliver a short oral decision at the conclusion of the hearing with its reasons to be put in writing and communicated to the parties at a later date, or it may reserve its decision. The decision of the Judicial Committee shall be binding upon notification to the Person concerned and/or his Union.
21.18.8 In the event that the Board’s Judicial Committee establishes that a Doping Offence has been committed, the Judicial Committee that heard the evidence shall impose sanctions on the Person concerned in accordance with Regulation 21.19.
21.18.9 A Person’s costs associated with any proceedings before a Judicial Committee dealing with a Doping Offence shall ordinarily be borne by the Person, including travel/accommodation costs of the Person, his representatives and his witnesses, as well as his legal costs.
21.18.10 A Judicial Committee dealing with a Doping Offence may, in its discretion, make an award of costs against the Person in respect of costs incurred by the Judicial Committee or other costs in relation to the investigation and/or proceedings where a sanction is imposed on the Person by the Judicial Committee.
21.18.11 Not withstanding the provisions of Regulation 21.18.9 and 21.18.10 above, the Judicial Committee shall retain absolute discretion in relation to the awarding of costs associated with the case and may make such order as to costs as they see fit.
21.18.12 Judicial Committees shall have the power to regulate their own procedure, in each case. However, subject to this power to regulate their own procedure Judicial Committees shall conform generally with the Procedural Guidelines set out below.
(a) As soon as reasonably practicable following the referral of the matter the Judicial Committee Chairman, or his designee, shall notify the Person of the date, place and time of the hearing at which the proceedings against him will be heard. The Person shall be informed that he is required to attend the hearing.
(b) A Person who is alleged to have committed a Doping Offence shall be entitled to be represented by an official of his Union, Rugby Body/Club, or by legal counsel. Where necessary an independent interpreter shall be present at a hearing of the Judicial Committee.
(c) In the interests of time and minimising inconvenience a Person whose hearing is pending can be required by the Judicial Committee, prior to the hearing, to supply it with full particulars of the case that will be presented on his behalf at the hearing.
(d) The Judicial Committee shall have the power to postpone or adjourn proceedings.
(e) The Judicial Committee shall be entitled to receive such evidence as it thinks fit (including evidence in writing), notwithstanding the evidence may not be legally admissible and shall be entitled to attach such weight to that evidence as it sees fit.
Generally the Judicial Committee shall apply the Best Evidence Rule. This means that first hand accounts from persons present at the hearing as to their observations / knowledge of the alleged Doping Offence in question should be preferred. Hearsay evidence may be accepted. However, caution will be exercised before hearsay evidence is accepted in preference to first hand evidence and generally less weight is likely to be given to hearsay evidence. Further, as a general rule, Judicial Committees should not permit the introduction of opinion evidence other than expert opinion evidence. Expert opinion evidence is only likely to be permitted when the evidence falls outside the every day knowledge of members of the Committee.
(g) The Judicial Committee shall be entitled to determine whether witnesses that give evidence are able to remain in the room in which the hearing is being heard after their evidence has been given.
(h) The Judicial Committee shall endeavour to ensure that proceedings are not heard in the absence of the Person subject to the proceedings. However, the non-attendance of a Person or his representative, after notice of the hearing has been provided, will not prevent the Judicial Committee from proceeding with the hearing in his absence. In arriving at its decision, the Judicial Committee may, however, take into account any written statement submitted by the Person or his representatives.
(i) Unless it otherwise directs, the procedure of the Judicial Committee at the hearing will be as follows:-
i) The Chairman will explain the procedure to be followed;
iii) Evidence from the Person (if he elects to give evidence) and from any witnesses to be called will be heard; and
(j) At any hearing the Judicial Committee will not be bound by Judicial Rules governing the procedure or the admissibility of evidence, provided that the hearing is conducted in a fair manner with a reasonable opportunity for the Person who is alleged to have committed a Doping Offence to submit evidence, address the Judicial Committee and present his case.
ii) The complaint will be read to the Person who it is alleged to have committed a Doping Offence and, where applicable, evidence will be presented by a representative of the Board;
iv) Submissions will be heard.
(k) In respect of any hearing in relation to a doping offence before a Judicial Committee the following will apply:
i) The hearing shall be held in private;
ii) Decisions shall be made by majority; and
iii) The Judicial Committee’s deliberations on its decision shall take place in private.
l) Where a Person is adversely affected by a decision of the Judicial Committee in relation to a Doping Offence, the Person shall be advised by the Judicial Committee of his right to appeal to a Board Appeal Committee.
m) Any deviation or deviations from the procedures set out in these Guidelines shall not invalidate any finding or decision of a Board Judicial Committee unless it was such as to cast real doubt on the reliability of such finding or decision.
21.19 Sanctions
21.19.1 For Doping Offences involving the detection of ephedrine, cathine, methylephedrine, and strychnine (the levels of which must not exceed the maximum levels set out in the WADA Prohibited List). The sanction shall be:
a) First offence: A maximum suspension of three (3) months.
b) Second offence: A maximum suspension of two (2) years.
c) Third and subsequent offences: A maximum suspension of five (5) years.
21.19.2 In relation to a Doping Offence involving the detection of any other Prohibited Substance or the use of a Prohibited Method the sanction shall be:
a) First Offence: A minimum suspension of two (2) years
b) Second offence: A lifetime ban.
21.19.3 In relation to a Doping Offence involving trading, trafficking, distributing, supplying, administering or selling any Prohibited Substance or Prohibited Method and/or where any Person procures, induces, counsels, assists, abets, covers up or incites (or who attempts to do any of the same) the use of a Prohibited Substance or Prohibited Method the sanction shall be a minimum of 4 years to a lifetime ban.
21.19.4 For the purposes of applying sanctions, a refusal or failure to provide a sample or submit to a drug test when requested to do so by an authorised official, or a failure to comply with Anti-Doping Regulations, shall be at a minimum suspension of two (2) years.
21.19.5 For the purposes of applying sanctions, a refusal or failure to provide Player whereabouts information for Out-of-competition testing purposes, shall be at a minimum a three (3) months and at a maximum, a two (2) year suspension.
21.19.6 The above sanctions may be applied to a Person regardless of any other sanction or penalty, its duration or timing or whether current or past, whether imposed by the Board, a Union, tournament organiser or any other sports organisation. However, the Board’s Judicial Committees and Appeal Committees and the disciplinary bodies of Unions or tournaments dealing with Doping Offences, shall recognise previous sanctions or penalties imposed by the Board, a Union, or tournament organiser or any other recognised sporting organisation in determining whether the Doping Offence is the Person’s first or second (or subsequent) Doping Offence. A certificate from the Board, a Union, tournament organiser or any other recognised sporting organisation as to any other previous sanction or penalty and the facts and circumstances pertaining thereto, in relation to any Person, shall be regarded as conclusive.
21.19.7 In respect of all Doping Offences for which a sanction is not otherwise provided in these Regulations, appropriate sanctions may be imposed at the discretion of the relevant Board Judicial Committee.
21.19.8 The period of any suspension imposed in respect of a Doping Offence shall ordinarily commence on the date on which any final decision thereon was made by the Judicial/Appeal Committee.
21.19.9 The Judicial/Appeal Committee shall be entitled at their discretion to set off time served as part of a provisional suspension against the full suspension imposed following a hearing. Any suspension imposed shall be continuous.
21.19.10 For the purposes of this Regulation, suspension shall mean that the Person suspended shall not be entitled to play, train as part of a team/squad, referee, touch judge, coach, select, organise, administer or promote Rugby Football in any Union in membership of the Board. In the event that a Person breaches the terms of a suspension imposed or recognised by either the Board, a Union or a tournament organiser for the commission of a Doping Offence, then that Person may be subject to a life-time ban from the Game or such other sanction as the Board shall deem appropriate.
21.19.11 All Doping Offences found to have been committed will be publicly announced. The Board, Union(s) or tournament organisers responsible for conducting or arranging the drugs test may also publish as they think fit, parts of proceedings, findings and sanctions penalties in respect of Doping Offences.
21.19.12 Once the period of a Person’s suspension has expired, subject to any conditions imposed upon his re-instatement (and provided the Person has made himself available for Out-of-competition testing during the period of suspension), the Person concerned will become automatically re-eligible. No application by a Person or his Union is necessary.
21.19.13 Conditions of reinstatement may include, but shall not be limited to, the following:
a) a requirement that the Person submit up to a maximum of three negative urine tests for all Prohibited Substances and Prohibited Methods during the suspension, the timing of which shall be determined by the Anti- Doping Advisory Committee.
21.21.1 Any Person who has been found by a Board Judicial Committee to have committed a Doping Offence shall be entitled to appeal against the finding and/or sanction imposed to an Appeal Committee. Pending the decision of the Appeal Committee the Person shall not be entitled to participate in the Game or in any activities associated with the Game in any Union in membership of the IRB.
b) a requirement that a suspended Person seek medical evaluation.
c) making reinstatement subject to the review and approval of a Player’s medical condition by an appropriate body, (for example, the Anti-Doping Advisory Committee).
21.20 Elimination or reduction of Sanctions based on Exceptional Circumstances
No Fault of Negligence
21.20.1 If the Person establishes in an individual case involving a Doping Offence under Regulation 21.1.1(a) (presence of Prohibited Substance or its Metabolites or Markers) or use of a Prohibited Substance or Prohibited Method under Regulation 21.1.1(b) that he bears No Fault or Negligence for the Doping Offence, the otherwise applicable sanction shall be eliminated. When a Prohibited Substance or its Markers or Metabolites is detected in an Person’s body tissue or fluids in violation of Regulation 21.1.1(a), the Person must also establish how the Prohibited Substance entered his system in order to have the sanction eliminated. In the event this Regulation is applied and the sanction otherwise applicable is eliminated, the Doping Offence shall not be considered a Doping Offence for the limited purpose of determining the sanctions for multiple violations under Regulations 21.19.1 and 21.19.2.
No Significant Fault or Negligence
21.20.2 This Regulation 21.20.2 applies to Doping Offences involving Regulation 21.1.1(a) (presence of Prohibited Substance or its Metabolites or Markers), use of a Prohibited Substance or Prohibited Method under Regulation 21.1.1(b), failing to submit to sample collection under Regulation 21.1.2, or administration of a Prohibited Substance or Prohibited Method under Regulation 21.1.3. If a Person establishes in an individual case involving such violations that he bears No Significant Fault or Negligence, then the sanction may be reduced, but the reduced sanction may not be less than one-half of the minimum sanction otherwise applicable. If the otherwise applicable sanction is a lifetime, the reduced period under this section may be no less than 8 years. When a Prohibited Substance or its Markers or Metabolites is detected in a Person’s body tissue or fluids in violation of Regulation 21.1.1(a) (presence of Prohibited Substance), the Person must also establish how the Prohibited Substance entered his system in order to have the sanction reduced.
21.21 Appeals
21.21.2 A Person shall have 14 days from the date of notification of the decision of the Judicial Committee in which to appeal. A Notice of Appeal signed by the Person must be lodged with the Appeal Committee Chairman within 14 days of the decision of the Judicial Committee and shall specify:
a) The name of the Appellant;
b) the decision appealed against;
c) the date of the decision appealed against; and
d) the specific grounds of appeal. Except as provided, no specific form of a notice of appeal is required.
21.21.3 The Appeal Committee shall be made up of (3) three members of the Appeal Panel and shall ordinarily comprise:
b) a senior legal practitioner who shall act as Chairman; and
c) an experienced medical practitioner with knowledge of doping in sport and the WADA Anti Doping Code; and
d) Either a second person from category (a) or (b) above or an ex-Player or Rugby Football administrator with relevant knowledge and experience.
21.21.4 If a Member of the Appeal Committee is unable or unwilling, for whatever reason, to hear the appeal, then the Board may, at its absolute discretion:
a) appoint a replacement; or
b) appoint a new Appeal Committee;
c) allow the remaining members of the Appeal Committee to hear the appeal.
21.21.5 The Appeal Committee shall determine the basis upon which any appeal will proceed. It may, however, in its discretion rehear the whole or any part of the evidence given before the Judicial Committee as it considers appropriate.
21.21.6 Where any question of fact arises on an appeal before the Appeal Committee it may be determined by reference to the record of proceedings before the Judicial Committee. However, the Appeal Committee, in its discretion, may rehear or receive written evidence in respect of the whole or any part of the evidence given before the Judicial Committee as it considers appropriate.
21.21.7 Appeal Committees shall be entitled to call on experts to provide specialist advice, including legal advice.
21.21.8 The Appeal Committee will have full discretionary power to hear and receive such further evidence as it thinks fit, provided it is established by the appellant that such evidence was not, on reasonable enquiry, available at the time of the original hearing.
In any case where a witness required by the Appeal Committee refuses and fails to attend before the Appeal Committee, the Appeal Committee may decide whether or not to allow the evidence of that witness to be given in any other form.
21.21.10 Save where the Appeal Committee decides to hear the entire case de novo (in which circumstances the applicable first instance standards and burdens shall apply), the appellant shall have the burden of proving that the decision being challenged should be overturned or varied.
21.21.11 Appeal Committees may request that an IRB representative attend the appeal tribunal hearing.
21.21.12 The decision of the Appeal Committee shall be advised to the parties as soon as practicable after the conclusion of the hearing. When it considers it appropriate, the Appeal Committee may deliver a short oral decision at the conclusion of the hearing with its reasons to be put in writing and communicated to the parties at a later date, or it may reserve its decision. The decision of the Appeal Committee shall be final and binding on notification to the Person concerned and/or his Union.
21.21.13 An appellant’s costs associated with any proceedings before the Appeal Committee shall, ordinarily, be borne by the appellant. The Appeal Committee shall, however, have full discretion in relation to the costs of Appeal Committee proceedings and may order any party or parties to pay some or all of the costs of proceedings under this Regulation 21 including the cost of holding the hearings, the cost of any interpreters and/or the legal and/or travel/accommodation costs of the members of the Appeal Committee, and/or the parties.
21.21.14 In exercising its jurisdiction the Appeal Committee shall have power to quash, suspend, vary or increase the sanction appealed against, subject to the mandatory nature of the penalties provided for under this Anti-Doping Regulation.
21.21.15 The Appeal Committee shall have the power to conduct and regulate the appeal proceedings as it sees fit having regard to the circumstances of the case. Although the Appeal Committee is entitled to regulate its own procedure it shall generally conform to the procedures stated in these Regulations and with the Procedural Guidelines set out below:
a) The Appeal Committee shall as a preliminary matter determine its prehearing procedures and hearing procedures.
b) The Appeal Committee shall be entitled to conduct a de novo hearing or hear the appeal based on the record of the decision of the Judicial Committee.
c) A Person shall have 14 days from the decision of the Judicial Committee in which to appeal. The signed Notice of Appeal must be lodged with the Appeal Committee Chairman within 14 days of the decision of the Judicial Committee and shall specify:
i) the name of the Appellant;
ii) the decision appealed against;
iii) the date of the decision appealed against; and
iv) the specific grounds of appeal
d) On receipt of the signed Notice of Appeal the Appeal Committee Chairman, or his designee, shall set a time, date and place for the hearing of the appeal which shall be notified to the Appellant.
e) The Appeal Committee Chairman shall be entitled as he sees fit to deal with pre-hearing procedural and/or evidential matters as may be applicable without reference to other members of Appeal Committees and may convene a pre-hearing conference for the purposes of giving directions for the hearing and clarification of the procedures.
f) Where the appellant appeals against the sanction and/or cost order alone, the appellant may request that the Appeal Committee review the sanction without the need for a personal hearing. The Appeal Committee may also determine that a personal hearing is not required in relation to any appeal but if he so wishes, the appellant always has the right to appear and make representations in all cases or alternatively he may make representations by telephone and/or in writing.
g) The Appellant may be represented before the Appeal Committee by legal counsel and/or a member of his Union and/or Rugby Body/Club. An independent interpreter may also be present where necessary.
h) A failure of the Appellant or his legal counsel or other representative to attend an Appeal Committee hearing shall not prevent the Appeal Committee proceeding with the hearing and making such decision as it considers appropriate.
i) The Appeal Committee shall have power to postpone or adjourn appeal proceedings.
j) The conduct of the hearing shall be as follows, unless the Appeal Committee directs otherwise:-
i) The Chairman will explain the procedure to be followed;
ii) Evidence from the Appellant (if any) and from any witnesses to be called by the Appellant;
iii) Where applicable evidence from the Board;
iv) Final submissions.
k) The Appeal Committee shall make its decisions by majority.
l) The Appeal Committee hearing and its deliberations shall be in private.
m) Any deviation or deviations from the procedures set out in these Guidelines shall not invalidate any finding or decision of a Board Appeal Committee unless it was such as to cast real doubt on the reliability of such finding or decision.
21.22 Recognition and Reporting Requirements
21.22.1 Where the Board determines a Doping Offence has been committed, every Union shall recognise the Doping Offence and sanction applied and shall take all necessary action to render such decision effective.
21.22.2 Each Union or tournament organiser (as the case may be) shall submit to the Board’s CEO a full report of the proceedings and conclusions of all hearings resulting from Doping Offences arising out of or within its jurisdiction within 14 days of the final decision on the Doping Offence having been made. Such cases shall be considered by the Board’s Anti-Doping Advisory Committee, which may on b0ehalf of the Board, accept the result or refer the matter to a Board Appeal Committee for further consideration.
21.22.3 Unless a case is submitted to a Board Appeal Committee for further consideration, Doping Offences established by a Union or tournament organiser and sanctions imposed shall, when recognised by the Board, be final and binding on all Unions who shall take the necessary action to render such result and sanctions effective. If a matter is submitted to a Board Appeal Committee then the final decision of that Committee will be final and binding upon the Board and all Unions.
21.22.4 If the CEO of the Board believes that a Union is not applying, or in a particular case did not apply, appropriate anti-doping regulations in accordance with these Regulations and the Guidelines, or failed to apply its regulations properly or in
21.23 General
21.23.1 Any deviation or deviations from the Anti-Doping Regulations and/or the Guidelines does not invalidate any finding, decision or positive test result unless such deviation or deviations are such to cast material doubt on any finding, decision or positive test result.
21.23.2 The Council may, on behalf of all Unions, recognise the results of drugs tests carried out by a sporting body other than the Board, Unions or tournament organisers, (or by a member of another sporting body), under rules and procedure different from the Board, provided that the Board is satisfied that the test was carried out properly and the rules of the body conducting the test afforded sufficient protection to the person concerned. If the Board does recognise the results of such a test then all Unions shall take all necessary action to ensure that this decision is effective. For the avoidance of doubt, the burden is on a person who is subject to a suspension imposed under the rules of another sporting body to prove that he should be entitled to play the Game on the grounds that the suspension he has received was improperly imposed.
21.23.3 The IRB may as appropriate recognise sanctions or penalties imposed by public authorities in respect of doping related matters whether specifically defined hereunder or otherwise, and may recognise and/or impose (as the case may be) appropriate sports based sanctions, including without limitation the sanctions provided for in these Regulations.
21.23.4 The Board may amend these Anti-Doping Regulations from time to time.
21.23.5 Any person who submits data and/or medical information to the IRB in accordance with these Regulations agrees that such information may be utilised by the IRB for the purposes of the implementation of the Anti-Doping Regulations.
21.24 Admissions
21.24.1 A Person may choose for the purposes of dispensing with the disciplinary process to admit that he has committed a Doping Offence at any time including an admission of a Doping Offence which is not the subject of a sample.
21.24.2 Any such admission shall be evidenced in writing for the purposes of this provision by the Person making such admission. Any Person who makes such an admission will be subject to the prescribed sanction under Regulation 21.19 without the necessity of completing other aspects of the disciplinary process. good faith, that Union renders itself liable to disciplinary action in accordance with Regulation 18.
21.25 Unforeseen Circumstances
21.25.1 In the event that a doping related incident arises for which there is no provision in this Regulation 21 then the CEO of the Board, or his nominee may take such action that he considers appropriate in the circumstances in accordance with general principles of natural justice and fairness.
21.26 Exceptional Circumstances
21.26.1 In exceptional circumstances where it has grounds to believe that there has been a misapplication of the applicable Anti-Doping Regulations and acting on the advice of the Anti-Doping Advisory Committee, the Board shall be entitled to require as it deems fit that the relevant Union(s) provisionally suspend such Person(s) from any involvement in the sport pending the final determination of the matter.
It is the responsibility of each Union in membership of the IRB to ensure that in such circumstances it is able by reference to its anti-doping regulations or otherwise, to effect and/or recognise such provisional suspension of the Person(s) concerned.
1. DOPING CONTROL
PROCEDURAL GUIDELINES (“GUIDELINES”)
a) These Guidelines should be followed as far as is reasonably practicable. However, any deviation or deviations from the procedures set out in the Guidelines shall not invalidate a finding of a Doping Offence unless it was such as to cast real doubt on the reliability of such a finding.
In-competition means a drug test, which takes place during or shortly after a Person’s participation, or scheduled participation, in a Match.
SCHEDULE 1
REGULATION 21
b) In this Schedule 1 unless the context otherwise requires:
Chaperone means a person appointed to assist in the doping control process and who is under the direct control of the DCO. Such Chaperones shall be independent and will notify the selected player of their selection for doping control, accompany and keep the Player in direct view from the time of notification until after the player provides a suitable sample.
Doping Control Officer (DCO) means the authorised Doping Control Official appointed and responsible for conducting and overseeing the sample collection procedures. The DCO shall be independent and properly trained in sample collection procedures. The DCO may also perform the duties of a Chaperone.
WADA Accredited Laboratory means a laboratory accredited by WADA as qualified to undertake the detection of Prohibited Substances and Prohibited Methods.
IRB Anti-Doping Representative means a Person who may be appointed by the Board to ensure the IRB’s Anti Doping Procedures and Guidelines are carried out.
Metabolites means any substance produced by a biotransformation process.
Markers means a compound, group of compounds or biological parameters that indicate the use of a Prohibited Substance or Prohibited Method.
Out-of-competition means a drug test which does not take place In-competition.
Person means a Player, trainer, referee, touch judge, coach, selector, medical officer, physiotherapist or any other individual who is or has been at any time involved in the Game, or in the organisation, administration or promotion of the Game.
Player means a Person who is selected for a Match either as a member of the team selected to start the Match or as one of the named substitutes/replacements, or a Person selected for an out-of competition drug test.
Players Representative means a Person who may accompany the selected Player within the Doping Control Station to oversee on the selected Players behalf, the division and sealing of the sample and accompanying documentation procedures. The representative shall also be from the same Union as the Player and have appropriate accreditation to access the venue area in which the Doping Control Station is located.
WADA means the World Anti Doping Agency.
2. DOPING CONTROL STATION
a) For In-competition doping control the host Union or tournament organiser shall provide a Doping Control Station.
(i) The Doping Control Station shall be secure and comprise of a waiting room, a processing area and a toilet (WC). The processing area shall be separate to the waiting area and should be private. The toilet should also be within the Doping Control Station.
(ii) The Doping Control Station shall be furnished to enable sample collection to be carried out. This is the responsibility of the host Union or tournament organiser.
(iii) The DCO shall provide the sample collection equipment necessary to conduct the doping control session.
(iv) Security shall be provided on the entrance to the Doping Control Station or the DCO shall require a set of keys to the Doping Control Station for the duration of the testing session.
(v) No photography, video or tape recordings may be taken inside the Doping Control Station during the sample collection or sealing procedure.
(vi) No media are permitted in the Doping Control Station while the doping control program is in operation.
(vii) A range of sealed, chilled non-alcoholic, non-caffeinated drinks should be available in the waiting area of the Doping Control Station to allow Players to rehydrate. These drinks should also be offered to the selected Players at the time of notification.
(viii) The DCO shall be responsible for ensuring that the Doping Control Station is clearly identified; that the facilities are clean and that the necessary furniture and fit out of the area in which doping control will take place has been provided and is acceptable.
3. AUTHORISED DOPING CONTROL OFFICIALS
a) For In-competition doping control, a sample collection team should consist of at a minimum one DCO and four Chaperones.
b) Chaperones must be of the same gender as those Players for whom they are collecting samples and must be over the age of eighteen.
c) The DCO and all Chaperones shall carry an identification card and/or a letter entitlement to collect samples from Players. Such identification should be shown to a Player when that Player is notified of his selection for a drug test.
d) The DCO, Chaperones and any IRB Anti Doping Representative shall be issued with tournament accreditation (where existing) that will grant them access to the venue and to areas within the venue in which they may require to accompany a player for doping control.
4. SELECTION OF PLAYERS - IN-COMPETITION
a) The selection of Players for doping control will be by the use of the numbered card system. The selection should, ordinarily, take place at least 1 hour prior to the commencement of the match or as soon as practicable within this period.
b) The selection of players will take place in the Doping Control Station or in a private pre-agreed location by all parties involved.
c) The DCO will arrange for the random draw to be made by the two team managers or their delegated representatives. The IRB Anti Doping Representative may also be present.
d) The DCO shall provide a set of cards for each team numbered from 1 to the number corresponding to the total number of Players and replacements/substitutes participating in the Match as appearing on the official team list.
e) Each set of cards shall then be placed as to expose only the reverse side which does not show any number. The cards shall then be rearranged. Each team manager shall select two cards of their own choice and sign the reverse side of each card. The team manager shall also record the name of their team on each card that they sign.
f) Each team manager shall also select a third card and mark this with “R” in addition to the team manager’s signature and the name of their team. This may be used in the case of where a Player is seriously injured and requires immediate hospitalisation.
g) At no stage are the selections to be made known to the Team Manager or any other party outside of the authorised doping control team until the end of the match.
h) The Board shall have the right to request, without justifying the reason, that any player undergo doping control at any time during an IRB tournament or designated event. This may be a directed selection of a Player/s rather then a random selection or may be in addition to the random selections. The IRB Anti Doping Representative or member of the IRB Anti Doping Advisory Committee shall be the only person to enforce such selections.
i) A Player may be subject to doping control on more than one occasion during any IRB tournament or designated event.
j) Where a Player selected to undertake doping control is certified by the Match Doctor to have been so seriously injured during the Match as to require hospitalisation, then that team’s reserve “R” Player selected at the time of the random draw shall undertake the drug test.
k) Where a selected Player is seriously injured and requires immediate hospitalisation, the Match Doctor shall provide a brief written report to the DCO outlining the reasons for the Players hospitalisation and his inability to provide a sample for doping control. The reserve selection card shall then be used.
ii) Request information about the doping control procedure.
5. NOTIFICATION OF SELECTION – IN-COMPETITION
a) The Chaperone shall be advised of their selected Player from when the match begins. The DCO and Chaperones should be in a position within the venue where they have good vision of the selected Players during the match.
b) As soon as reasonably practicable after the conclusion of a Match and in a discrete manner the Chaperones shall identify the selected Players and notify them individually that they are required to submit to doping control. An interpreter may be sought to assist with notification.
c) A Player selected for doping control shall be handed a written notice by a Chaperone confirming that he is required to submit to doping control. The Player shall acknowledge notification by signing the Notification Form as soon as he has read the form.
d) The Chaperone shall record the time of notification and then sign the Notification Form.
e) A Chaperone shall accompany each Player selected from the time of notification until such time as the sample collection procedures have been concluded and the relevant documentation completed and signed. During this period, the Chaperone shall keep the Player under constant, direct supervision.
f) Players should attend the Doping Control Station as soon as possible following notification that they have been selected for doping control. In any event, the Player shall arrive at the Doping Control Station within one hour of being notified. The time of arrival should be recorded by the Chaperone or DCO on the Doping Control Form.
6. PLAYERS RIGHTS AND RESPONSIBILITIES
a) The Player will be advised by the Chaperone that he may;
i) Choose to be accompanied by a representative and an interpreter where appropriate in the Doping Control Station.
b) Under the direct supervision of a Chaperone and within one hour of notification a Player may:
(i) attend a victory ceremony.
(ii) fulfill media commitments.
(iii) perform a warm-down.
(iv) receive necessary medical attention.
(v) attend a team meeting.
(vi) change out of his playing uniform.
c) Team meetings that take place at the end of a match in which Players have been notified of their selection for doping control shall require at least one (1) Chaperone to be present within the meeting to ensure the selected players are kept under supervision. At the end of the team meeting the other Chaperone shall enter and supervise his selected Player.
d) It is a Players responsibility to ensure that:
(i) he is aware of and complies with the IRB Anti Doping Regulations.
(ii) he complies with the notification, sample collection and sealing procedures.
(iii) he arrives at the Doping Control Station within one hour of notification to provide his sample.
(iv) he controls the sample until it is sealed in the urine sample collection kit save where he gives the DCO approval to carry out the division and sealing process.
(v) the sealed urine sample collection kit is secure and identified.
(vi) he receives a copy of the Notification and Doping Control Forms.
7. FAILURE TO COMPLY WITH A REQUEST FOR DOPING CONTROL
a) If a Player refuses to sign the Notification Form the Chaperone shall inform the Player of the consequences regarding refusal or failure to report to the Doping Control Station and that it shall constitute a doping offence which may result in a 2 year sanction. If the player still refuses, the Chaperone should then immediately report this to the DCO who shall use his best endeavors to further inform the Player of his obligation to submit to doping control. The Players team manager should also be informed and involved in this process where possible.
b) If the Player still fails or refuses to sign the Notification Form and/or fails to report to the Doping Control Station he shall be deemed to have failed or refused to submit to doping control and to have thereby committed a Doping Offence.
c) The Chaperone shall note this on the Notification Form and sign it. The DCO will provide a written report on the actions involving the Players failure to comply and/or failure to report to the Doping Control Station.
8. ARRIVAL AT THE DOPING CONTROL STATION
(a) Only the following persons shall be authorised to attend the Doping Control Station:
(i) The Players selected for testing.
(ii) The Player’s representative, if any.
(iii) The Players interpreter (if appropriate).
(iv) The Doping Control Officer.
(iv) The Chaperones and;
(vi) The IRB Anti Doping Representative.
b) Once a Player has arrived at the Doping Control Station he shall be expected to remain until the sample collection, sample division and sealing procedures have been concluded and the relevant documentation completed.
c) A Player may only leave the Doping Control Station once he has completed the doping control process. However the Player may leave the Doping Control Station only on approval by the DCO and for a short agreed time. In this situation the Player shall be accompanied by a Chaperone who shall keep the Player under constant, direct supervision.
d) The Player may select a drink from the range of sealed, chilled non-alcoholic, noncaffeinated drinks provided. If a Player elects to consume other drinks or food then he does so at his own risk and cost.
10. DIVISION AND SEALING THE URINE SAMPLE
9. PROVIDING A URINE SAMPLE
a) The Player shall be requested to provide a minimum urine sample of 75ml however the Player should be urged to provide a greater amount if possible.
b) When the Player believes that he is ready to provide a urine sample he shall move from the waiting area to the processing area of the Doping Control Station. The player will be asked to select a sealed sample collection vessel. The Player should break the seal of the sample collection vessel, remove and check that the vessel is clean. The Player and the DCO shall then proceed to the toilet (WC) area. The Chaperone shall remain in the processing area with the Players Representative and or interpreter.
c) No one other than the DCO and the Player shall be present in the toilet (WC) when the urine is being provided by the Player.
d) To ensure authenticity of the sample, the Player shall be required to remove such clothing as is necessary so as to allow the DCO an unobstructed view of the Player urinating into the collection vessel.
e) When the Player signifies to the DCO that he has finished, the Player and the DCO shall return to the processing area. The Player shall keep control of the sample at all times. The DCO shall keep the collection vessel in sight at all times.
a) Upon returning to the processing area, the quantity of urine shall be measured by the DCO. If the quantity of urine is less than 75ml the partial sample procedure set out in section 14 of this Schedule 1 shall apply.
b) If the collection vessel contains approximately 75ml or more of urine, the Player shall select a sealed urine sample kit. The Player should check the security of the kit prior to opening it. If there is any evidence of tampering the Player should select a new urine sample kit. The Player will then be invited to break the security seals and remove the contents of the kit.
c) The following procedures must be carried out in the presence of the Player and the Players Representative, if any, and the DCO. The Player may request that the DCO carry out the sample division and sealing procedures.
d) The urine sample kits should contain two clean unused bottles. One bottle shall be marked sample “A” and one bottle sample “B” and will contain corresponding code numbers. The Player and his representative, if any, should check that the sample bottle codes correspond. The sample bottle codes should also correspond to the external code number on the urine sample kit. If either does not correspond then a new urine sample kit should be selected.
e) The Player’s sample shall then be divided between the “A” and the “B” sample bottles. It is recommended that the “A” sample contain approximately two thirds of the urine provided and the “B” sample contain the remaining third. If a large volume of urine is provided then each bottle shall be filled up to the maximum level permitted in each bottle. However, any shortfall in the amount of urine in either bottle after division shall not invalidate a test provided there is sufficient urine for the analysis to be adequately performed.
f) A residue of urine should be left in the bottom of the collection vessel so that the pH and specific gravity of the sample can be measured. g) Both the “A” and “B” bottles shall be tightly sealed by the Player and/or the DCO and checked for any leakage. The DCO shall record the “A” and “B” sample code number on the Doping Control Form. The Player and his representative, if any, should check this information is correct.
12. DECLARATION OF MEDICATION OR OTHER SUBSTANCES
a) The Player shall be asked by the DCO to declare any medications or any other substance the Player has taken during the previous 3 days. This declaration should be recorded on the Doping Control Form. declared medications. If the Player declines to make such a declaration this should also be recorded on the Doping Control Form.
b) If the Player declares more medications than the Doping Control Form has space for the DCO shall record the remainder of medications on a new Doping Control Form and attach it to the first Doping Control Form. The second Doping Control Form should be completed in the same way as the first with the exception of the additional
c) The Player should be asked if he has any comments on the procedures followed during the sample collection process. Any such comments should be recorded on the Doping Control Form.
11. pH and SPECIFIC GRAVITY TEST
a) The pH is a measure of how acidic or alkaline the sample is. The specific gravity is a measure of how concentrated or dilute the sample is. The pH and specific gravity test is to ensure that the sample is within the listed ranges and suitable for analysis.
b) The DCO shall measure, the pH and specific gravity of a Player’s urine using the residue volume of the urine remaining in the collection vessel after the sample has been sealed.
c) The criteria for acceptance of the sample shall be as follows:-
ii) pH - not less than 5 and not greater than 7
ii) specific gravity - not less than 1.010 - if using urine analysis strips. not less than 1.005 - if using a refractometer.
d) If the first sample does not meet these specifications a second sample will be requested. A second Doping Control Form will be required to be completed for the second sample. In the comments section of the second Doping Control Form the DCO shall list the urine sample kit code number of the first sample.
e) If the Player refuses to provide a second sample he should be notified that such refusal constitutes a Doping Offence. All samples collected from a Player shall also be linked on the Laboratory Advice Form.
f) If a Players first sample has a specific gravity reading below 1.010 for urine analysis strips or below 1.005 for a refractometer, the DCO should aim to collect the maximum amount of urine the sample bottles will hold. The DCO should also advise the Player to restrict any further intake of fluids.
13. SIGNING OFF THE DOPING CONTROL FORM
a) The DCO shall ask the Player and his representative if any, to check all the information on the Doping Control Form and if satisfied both the Player and his representative, if any, should sign the form. If the Player indicates his satisfaction with the sample collection procedures on the Doping Control Form this shall amount to conclusive evidence that such procedures were conducted properly.
b) The DCO shall then check and sign the Doping Control Form noting any irregularities or comments that he may have on the form.
c) The DCO will then provide a copy of the completed Doping Control Form to the Player who is then free to leave the Doping Control Station.
14. PARTIAL SAMPLE
a) If insufficient urine has been provided by a Player i.e. less than 75ml, the Players sample will be securely stored temporarily in a partial sample kit until such time as he provides further urine.
b) On returning from the toilet to the processing area the Player will then select a partial sample kit. The Player should check the security of the kit prior to opening it. If there is any evidence of tampering the Player should select a new partial sample kit.
c) The player shall then check that the partial kit bottle is clean before pouring the urine from the collection vessel into the partial sample kit bottle. The player shall then close the bottle and check that no leakage occurs.
d) The partial sample code will be recorded on the Doping Control Form along with the time of sample collection, volume of urine and the Players signature.
e) The Doping Control Form and partial sample shall be kept secure by the DCO until the Player is ready to provide another sample. The Player shall return to the waiting area and remain under observation by a Chaperone pending provision of his further sample.
f) When the Player is ready to provide more urine, a new sealed collection vessel should be selected by the Player. The Player shall be advised of the amount of urine required to meet the minimum 75ml level. The Player should again provide his sample under the direct observation of the DCO.
g) Before breaking the seal to open the partial sample, the DCO and the Player should check the code number on the seal of the bottle in which the Player’s partial sample is stored against the code previously recorded on the Doping Control Form. The Player and DCO shall ensure that the seal has not been tampered with. The Player shall then break open the partial kit.
h) The urine collected from the Player in the first collection shall be added to the urine collected from the second collection and the total volume checked by the DCO. If the sample is still insufficient in volume, the partial sample sealing and recording procedures shall be repeated.
i) Once a combined urine volume of 75ml has been provided the standard division and sealing procedures should be followed as set out in section 10 of this Schedule.
15. TRANSPORTATION OF SAMPLES
a) The sealed samples should be securely stored pending their dispatch to an IOC Accredited Laboratory for analysis.
b) All samples shall be sent by express courier to a WADA Accredited Laboratory as soon as reasonably practicable.
c) All samples forwarded to WADA Accredited Laboratories shall be placed in secure transport containers or bags. Copies of each Players Doping Control Form, which shall only contain details of the sample, declared medications and the sample code numbers shall accompany the samples. A summary of all sample codes collected, Laboratory advice and chain of custody information shall be recorded on the Doping Control Laboratory Advice Form also be forwarded to the WADA Accredited Laboratory with the sealed samples.
d) If sending the samples to an WADA Accredited Laboratory outside of the country of where the samples were collected a Customs Declaration may be required to accompany the secure transport containers or bags.
16. WADA ACCREDITED LABORATORY
a) The WADA Accredited Laboratory shall confirm receipt on arrival of the samples to the Board, Union or tournament organiser. The WADA Accredited Laboratory will check to ensure that the samples have arrived in good condition and have not been tampered with.
b) The WADA Accredited laboratory shall proceed to analyse the “A” sample for prohibited substances as per the WADA Prohibited List. The Board may test for other substances from time to time for monitoring purposes.
17. RESULT MANAGEMENT
a) If the “A” sample returns a negative result than the WADA Accredited Laboratory shall report this to the Board, Union or tournament organiser. The Board shall then notify the Union of the result . The Union should then notify the Player of this result.
b) If the A sample returns a positive result then procedures set out in the IRB Anti- Doping Regulations shall apply.
c) In line with the WADA Accredited Laboratories Operating Standards the Board will be notified of all positive test results for the sport of rugby regardless if Board did not coordinate the test.
18. OUT-OF-COMPETITION TESTING
a) Under the Boards Anti Doping Out-of-competition program the Board may select any Player under membership of a Union to undergo a doping control at any time or place.
19. SELECTION OF PLAYERS OUT-OF-COMPETITION
a) A Player may be selected for Out-of-competition testing by directed or random selection by the Board, Union or appointed Sample Collection Agency representative.
b) The Board may appoint a Sample Collection Agency to conduct Out-of-competition doping control on behalf of the IRB.
c) Such testing may be conducted unannounced or by way of an appointment made with a Player in advance by either an authorised doping control official or a representative of the Board.
d) Out-of-competition testing may take place during a Rugby Football season or out-ofseason and may occur at a training ground, residential accommodation or any other place where the Player is likely to be found.
e) Players and/or Unions on request from the Board will be required to provide Players personal and club training details along with National Squad/Team training sessions so that effective Out-of-competition testing can be conducted.
20. NOTIFICATION OF PLAYERS OUT-OF-COMPETITION
a) A Player may be notified for Out-of-competition doping control by either:
(i) “No notice” notification, where the DCO or Chaperone appears unannounced and notifies the selected Player in person. The selected Player is then kept under constant supervision until the sample is sealed and appropriate documentation completed.
(ii) “Short notice” notification, where the Player is informed by telephone or by written notification by an authorised doping control official and must report for sample collection to a designated location by a designated time (which will be no more than 24hrs from the time of verbal or receipt of written notification.
c) When a Player notified of his selection for a short notice doping control does not report to the doping control station at the designated time, the DCO shall use his judgment in waiting beyond the agreed time and/or attempting to contact the Player. Following this, if the Player has still not reported the DCO will report to the Board that the Player did not attend for the doping control. In these circumstances the Player may be deemed to have refused or failed to comply with a request for doping control and thereby may have committed a Doping Offence. a)
b) When an appointment has been made by a DCO or a representative of the Board with a Player to conduct short notice Out-of-competition doping control it is the responsibility of the Player (or, where relevant, his Union or Rugby Body/Club) to ensure that there is no confusion over the agreed date, time and location where the sample collection is to take place.
d) Where a DCO appointed by the Board to conduct no notice Out-of-competition doping control arrives unannounced, the DCO or Chaperone should give the Player a reasonable time to complete any activity in which he is engaged. Such activity should be within the DCO’s or Chaperones clear and continuous view.
e) No notice doping control should commence as soon as reasonably practicable after a Player has been notified. In the case where the selected Player is participating in a team training session, the Player may complete the session under direct view of a DCO or Chaperone before presenting for doping control.
l) In all other respects the sample collection process shall, as far as reasonably practicable, take place in accordance with the Doping Control Procedural Guidelines for In-competition testing.
f) The DCO or Chaperone should attempt to notify the selected player/s at their training venue/s as a first preference. If the DCO or Chaperone is unable to make contact with the player then the DCO or Chaperone will notify the player wherever possible.
g) When the DCO or Chaperone makes contact with the Player who is the subject of Out-of-competition doping control he should show the Player;
i) A valid form of identification; and
ii) A letter from the Board authorising the DCO or Chaperone to conduct doping control on its behalf.
h) Prior to undertaking the sample collection the DCO shall request the Player to produce photo identification or satisfy himself of the identify of the Player to be tested.
i) The DCO shall make every effort to collect the urine samples as discreetly as possible and with maximum privacy. It must be recognised that certain circumstances may impose difficulties on the DCO that cannot be easily overcome.
j) If the facilities are not suitable at the venue where notification took place the DCO may conduct doping control on the selected Player at another location. The DCO will make this decision. The Player may not leave the venue of notification unless the DCO permits and will be accompanied by the DCO or Chaperone at all times if the testing session is to be relocated.
k) If the Player wishes to leave the venue against the DCO’s decision the DCO shall inform the Player that he is required to provide a sample for Out-of-competition testing at the current location and outline the possible consequences of not complying with a request to provide a sample and that it constitutes a doping offence in accordance with the IRB Anti Doping Regulations. If the Player still does not comply, then a failure to comply is recorded. The DCO shall compile a written report relating to the circumstances of the refusal.
>SCHEDULE 2
REGULATION 21
THE 2004 PROHIBITED LIST WORLD ANTI-DOPING CODE Valid 26 March 2004 (Updated 17 March 2004)
SUBSTANCES AND METHODS
PROHIBITED IN-COMPETITION
PROHIBITED SUBSTANCES
S1. STIMULANTS
The following stimulants are prohibited, including both their optical (D- and L-) isomers where relevant:
*** The substances included in the 2004 Monitoring Program are not considered as Prohibited Substances.
Adrafinil, amfepramone, amiphenazole, amphetamine, amphetaminil, benzphetamine, bromantan, carphedon, cathine*, clobenzorex, cocaine, dimethylamphetamine, ephedrine**, etilamphetamine, etilefrine, fencamfamin, fenetylline, fenfluramine, fenproporex, furfenorex, mefenorex, mephentermine, mesocarb, methamphetamine, methylamphetamine, methylenedioxyamphetamine, methylenedioxymethamphetamine, methylephedrine**, methylphenidate, modafinil, nikethamide, norfenfluramine, parahydroxyamphetamine, pemoline, phendimetrazine, phenmetrazine, phentermine, prolintane, selegiline, strychnine, and other substances with similar chemical structure or similar pharmacological effect(s)***.
* Cathine is prohibited when its concentration in urine is greater than 5 micrograms per millilitre.
** Each of ephedrine and methylephedrine is prohibited when its concentration in urine is greater than 10 micrograms per millilitre.
S2. NARCOTICS
The following narcotics are prohibited: buprenorphine, dextromoramide, diamorphine (heroin), hydromorphone, methadone, morphine, oxycodone, oxymorphone, pentazocine, pethidine.
S3. CANNABINOIDS
Cannabinoids (e.g. hashish, marijuana) are prohibited.
S4. ANABOLIC AGENTS
Anabolic agents are prohibited.
1. Anabolic Androgenic Steroids (AAS)
a. Exogenous* AAS including but not limited to: androstadienone, bolasterone, boldenone, boldione, clostebol, danazol, dehydrochloromethyltestosterone, delta1-androstene-3,17-dione, drostanolone, drostanediol, fluoxymesterone, formebolone, gestrinone, 4-hydroxytestosterone, 4- hydroxy-19-nortestosterone, mestanolone, mesterolone, methandienone, metenolone, methandriol, methyltestosterone, mibolerone, nandrolone, 19-norandrostenediol, 19-norandrostenedione, norbolethone, norethandrolone, oxabolone, oxandrolone, oxymesterone, oxymetholone, quinbolone, stanozolol, stenbolone, 1-testosterone (delta1-dihydro-testosterone), trenbolone and other substances with similar chemical structure of similar pharmacological effect(s)#.
b. Endogenous** AAS including but not limited to: androstenediol, androstenedione, dehydroepiandrosterone (DHEA), dihydrotestosterone, testosterone, and other substances with similiar chemical structure or similiar pharmacological effect(s)#.
Where a Prohibited Substance (as listed above) is capable of being produced by the body naturally, a Sample will be deemed to contain such Prohibited Substance where the concentration of the Prohibited Substance or its metabolites or markers and/or any other relevant ratio(s) in the Athlete’s Sample so deviates from the range of values normally found in humans so as not to be consistent with normal endogenous production. A Sample shall not be deemed to contain a Prohibited Substance in any such case where the Athlete proves by evidence that the concentration of the Prohibited Substance or its metabolites or markers and/or the relevant ratio(s) in the Athlete’s Sample is attributable to a pathological or physiological condition. In all cases, and at any concentration, the laboratory will report an adverse finding if, based on any reliable analytical method, it can show that the Prohibited Substance is of exogenous origin.
If the laboratory result is not conclusive and no concentration as referred to in the above paragraph is found, the relevant Anti-Doping Organization shall conduct a further investigation if there are serious indications, such as a comparison to reference steroid profiles, for a possible Use of a Prohibited Substance. If the laboratory has reported the presence of a T/E ratio greater than six (6) to one (1) in the urine, further investigation is obligatory in order to determine whether the ratio is due to a physiological or pathological condition.
In both cases, the investigation will include a review of any previous tests, subsequent tests and/or results of endocrine investigations. If previous tests are not available, the Athlete shall undergo an endocrine investigation or be tested unannounced at least three times within a three month period.
Failure of the Athlete to co-operate in the investigations will result in considering the Athlete’s Sample to contain a Prohibited Substance.
2. Other Anabolic Agents Clenbuterol, zeranol.
For purposes of this section:
* “exogenous” refers to a substance which is not capable of being produced by the body naturally.
** “endogenous” refers to a substance which is capable of being produced by the body naturally.
S5. PEPTIDE HORMONES
The following substances, including other substances with similar chemical structure or similar pharmacological effect(s), and their releasing factors, are prohibited.
1. Erythropoietin (EPO)
2. Growth hormone (hGH) and Insulin-like Growth Factor (IGF-1)
3. Chorionic Gonadotrophin (hCG) prohibited in males only;
4. Pituitary and synthetic gonadotrophins (LH) prohibited in males only;
5. Insulin
6. Corticotrophins
Unless the Athlete can demonstrate that the concentration was due to a physiological or pathological condition, a Sample will be deemed to contain a Prohibited Substance (as listed above) where the concentration of the Prohibited Substance or its metabolites and/or relevant ratios or markers in the Athlete’s Sample so exceeds the range of values normally found in humans so as not to be consistent with normal endogenous production.
The presence of other substances with similar chemical structure or similar pharmacological effect(s), diagnostic marker(s) or releasing factors of a hormone listed above or of any other finding which indicate(s) that the substance detected is not the naturally present hormone, will be reported as an adverse analytical finding.
S6. BETA-2 AGONISTS
All beta-2 agonists including their D- and L- isomers are prohibited except that formoterol, salbutamol, salmeterol and terbutaline are permitted by inhalation only to prevent and/or treat asthma and exercise-induced asthma/broncho-constriction. A medical notification in accordance with section 8 of the International Standard for Therapeutic Use Exemptions is required.
Despite the granting of a TUE, when the Laboratory has reported a concentration of salbutamol (free plus glucuronide) greater than 1000 ng/mL, this will be considered as an adverse analytical finding unless the athlete proves that the abnormal result was the consequence of the therapeutic use of inhaled salbutamol.
S7. AGENTS WITH ANTI-OESTROGENIC ACTIVITY
Aromatase inhibitors, clomiphene, cyclofenil, tamoxifen are prohibited only in males.
S8. MASKING AGENTS
Masking agents are prohibited. They are products that have the potential to impair the excretion of Prohibited Substances, to conceal their presence in urine or other Samples used in doping control, or to change haematological parameters.
Masking agents include but are not limited to: Diuretics*, epitestosterone, probenecid, plasma expanders (e.g. dextran, hydroxyethyl starch.)
*A medical approval in accordance with section 7 of the International Standard for Therapeutic Use Exemptions is not valid if an Athlete’s urine contains a diuretic in association with threshold or sub-threshold levels of a Prohibited Substance(s).
Diuretics include : acetazolamide, amiloride, bumetanide, canrenone, chlortalidone, etacrynic acid, furosemide, indapamide, mersalyl, spironolactone, thiazides (e.g. bendroflumethiazide, chlorothiazide, hydrochlorothiazide) and triamterene, and other substances with similar chemical structure or similar pharmacological effect(s).
S.9 GLUCOCORTICOSTEROIDS
Glucocorticosteroids are prohibited when administered orally, rectally, or by intravenous or intramuscular administration.
All other administration routes require a medical notification in accordance with section 8 of the International Standard for Therapeutic Use Exemptions.
PROHIBITED METHODS
M1. ENHANCEMENT OF OXYGEN TRANSFER
The following are prohibited:
a. Blood doping. Blood doping is the use of autologous, homologous or heterologous blood or red blood cell products of any origin, other than for legitimate medical treatment.
b. The Use of products that enhance the uptake, transport or delivery of oxygen, e.g. erythropoietins, modified haemoglobin products including but not limited to haemoglobin-based blood substitutes, microencapsulated haemoglobin products, perfluorochemicals, and efaproxiral (RSR13).
M2. PHARMACOLOGICAL, CHEMICAL AND PHYSICAL MANIPULATION
Pharmacological, chemical and physical manipulation is the Use of substances and methods, including masking agents, which alter, attempt to alter or may reasonably be expected to alter the integrity and validity of specimens collected in doping controls.
These include but are not limited to catheterisation, urine substitution and/or tampering, inhibition of renal excretion and alterations of testosterone and epitestosterone concentrations.
M3. GENE DOPING
Gene or cell doping is defined as the non-therapeutic use of genes, genetic elements and/or cells that have the capacity to enhance athletic performance.
SUBSTANCES AND METHODS PROHIBITED IN- AND OUT-OF-COMPETITION
PROHIBITED SUBSTANCES
(All categories listed hereunder refer to all those substances and methods listed in the relevant section)
S4. ANABOLIC AGENTS
S5. PEPTIDE HORMONES
S6. BETA-2 AGONISTS*
S7. AGENTS WITH ANTI-OESTROGENIC ACTIVITY
S8. MASKING AGENTS
(*Only clenbuterol, and salbutamol when its concentration in urine is greater than 1000ng/mL)
PROHIBITED METHODS
M1. ENHANCEMENT OF OXYGEN TRANSFER
M2. PHARMACOLOGICAL, CHEMICAL AND PHYSICAL MANIPULATION
M3. GENE DOPING SUBSTANCES PROHIBITED IN PARTICULAR SPORTS
P.1 ALCOHOL
Alcohol (ethanol) is prohibited in-Competition only, in the following sports. Detection will be conducted by breath analysis and/or blood. The doping violation threshold for each
Federation is reported in parenthesis. If no threshold is indicated, the presence of any quantity of alcohol shall constitute a doping violation.
Aeronautic (FAI) (0.20 g/L)
Archery (FITA) (0.10 g/L)
Automobile (FIA)
Billiards (WCBS)
Boules (CMSB) (0.50 g/L)
Gymnastics (FIG) (0.10 g/L)
Karate (WKF) (0.40 g/L)
Modern Pentathlon (UIPM) (0.10 g/L) for the modern pentathlon discipline
Motorcycling (FIM)
Roller Sports (FIRS) (0.02 g/L)
Skiing (FIS)
Triathlon (ITU) (0.40 g/L)
Wrestling (FILA)
P.2 BETA-BLOCKERS
Unless otherwise specified, beta-blockers are prohibited in-Competition only, in the following sports.
Aeronautic (FAI)
Archery (FITA) (also prohibited out of competition)
Automobile (FIA)
Billiards (WCBS)
Bobsleigh (FIBT)
Boules (CMSB)
Bridge (FMB)
Chess (FIDE)
Curling (WCF)
Gymnastics (FIG)
Motorcycling (FIM)
Modern Pentathlon (UIPM) for the modern pentathlon discipline
Nine-pin bowling (FIQ)
Sailing (ISAF) match race helms only
Shooting (ISSF) (also prohibited out of competition)
Skiing (FIS) ski jumping & free style snow board
Swimming (FINA) in diving & synchronised swimming
Wrestling (FILA)
Beta-blockers include, but are not limited to, the following: acebutolol, alprenolol, atenolol, betaxolol, bisoprolol, bunolol, carteolol, carvedilol, celiprolol, esmolol, labetalol, levobunolol, metipranolol, metoprolol, nadolol, oxprenolol, pindolol, propranolol, sotalol, timolol.
P.3 DIURETICS
Diuretics are prohibited in- and out- of competition in all sports as masking agents. However, in the following weight-classified sports and sports where weight loss can enhance performance, no Therapeutic Use Exemptions shall be granted for use of diuretics.
Body-Building (IFBB)
Boxing (AIBA)
Judo (IJF)
Karate (WKF)
Powerlifting (IPF)
Rowing (Light-Weight) (FISA)
Skiing (FIS) for Ski Jumping only
Taekwondo (WTF)
Weightlifting (IWF)
Wrestling (FILA)
Wushu (IWUF)
SPECIFIED SUBSTANCES*
“Specified Substances” are listed below:
Stimulants: ephedrine, L-methylamphetamine, methylephedrine.
Cannabinoids.
Inhaled Beta-2 Agonists (except clenbuterol).
Diuretics (this does not apply to section P3).
Masking Agents: probenecid.
Glucocorticosteroids
Beta Blockers
Alcohol
*; The WADA Code (10.3) states “The Prohibited List may identify specified substances which are particularly susceptible to unintentional anti-doping rule violations because of their general availability in medicinal products or which are less likely to be successfully abused as doping agents.” A doping violation involving such substances may result in a reduced sanction as noted in the Code provided that the “…Athlete can establish that the Use of such a specified substance was not intended to enhance sport performance…”
Note: For more information on the 2004 Prohibited List please go to the WADA website at www.wada-ama.org
• In accordance with IRB Regulation [21.7.1], all Players participating in any rugby sporting activity conducted by or under the auspices of the IRB are required to have prior written approval by a prescribing physician for the therapeutic use of the specified Prohibited Substances below.
• A declaration for use of the Prohibited Substance as per IRB Regulation [21.7.1 (a)] is valid for ONE (1) YEAR ONLY from the date it is received by the IRB Anti Doping Representative or the Players National Union pending on the level of the Player.
• Declarations for use of the Prohibited Substance as per IRB Regulation [21.7.1 (b)] are valid for usage in that particular Match, Series of Matches or Tournament on receipt by the IRB Anti Doping Representative or the Players National Union depending on the level of the Player.
Substances Prohibited Authorised with Declaration 21.7.1 (a) Beta 2 Agonists
Formeterol, Salbutamol, Salmeterol and Terbutaline. Oral Systemic Injections Inhalator only to prevent and/or treat asthma and exercised induced asthma 21.7.1 (b)
Glucocorticosteroids Systematic use when administered orally, rectally or by intravenous or intramuscular injection. Local or Intra–articular Injections, topical, anal, aural, ophthalmic and inhalation
Schedule 3
IRB Fax Number ABBREVIATED THERAPEUTIC USE EXEMPTION +353 1 2409 289
DECLARATION OF MEDICATION FORM
PART A – Player Information
First Name: Surname: Date of Birth:
National Union: Team/Club: Gender: Male Female
PART B – Notifying Prescribing Physician and Medical Information
Name: Qualifications:
Contact Address: Telephone (W):
Mobile: Email: Fax:
Diagnosis: Medical Examination(s)/test(s) performed:
Name(s) of Prohibited Substance(s): Dose of administration:
Route of Administration: Frequency of administration:
Anticipated duration of this medication plan:
PART C – Prescribing Physician Declaration I,………………………………………....certify the above mentioned substance/s for the above named Player has been/are to be administered as the correct treatment for the above named medical condition. I further certify that the use of alternative medications not on the Prohibited List would be unsatisfactorily for the treatment of the above named medical condition.
Prescribing Physicians Signature: _______________________________ Date: _________________________
PART D – Players Declaration I,…………………………………..certify that the information under Part A is accurate and that I am requesting approval to use a Substance from the WADA Prohibited List. I authorise the release of personal medical information to the International Rugby Board as well as to WADA staff and to the WADA TUEC as well as to other Anti Doping Organisations (ADO’s) under the provisions of the Code.
Player’s Signature: ________________________________ Date: _________________________
Parent / Guardian Signature: ________________________ Date: _________________________
(if a Player is a minor a parent or guardian shall sign together with or on behalf of the Player)
Official Holder of Declaration of Medication Records and Criteria
• IRB - Players competing in any International Match/Tournament must submit this declaration to the IRB FAX No. +353 1 2409 289
• National Unions – any Player outside of the above criteria must submit this declaration to their National Union only.
Articole similare
19 Apr. 2026
FRANȚA / PRO D2 / ETAPA A 27-A: Cinci echipe cu români se luptă să evite subsolul clasamentului
Runda cu numărul 27 din Pro D2, a doua divizie a campionatului Franței la rugby, n-a fost una tocmai fericită pentru toți românii care activează acolo. Cu Romeo Gontineac antrenor...
18 Apr. 2026
LRK 2026 / ETAPA A 4-A / RCGH - CSRAP 15-67: Încă un eșec... Și ce dacă! Rugby-ul nu este doar despre scor, ci mai ales despre oameni
Pătrunsă în elita rugby-ului românesc în acest an, RC Gura Humorului a disputat al 3-lea meci din Liga de Rugby Kaufland 2026. Și s-a înclinat pe teren propriu, astăzi...
18 Apr. 2026
LRK 2026 / ETAPA A 4-A / CMSBM - CSAST 50-33: Maramureșenii au obținut un succes clar în fața marilor rivali din Capitală
Ultima partidă a etapei cu numărul 4 a Ligii de Rugby Kaufland 2026, din punct de vedere cronologic, s-a încheiat cu un succes clar al formației gazdă. Evoluând pe Arena Zimbrilor din...
18 Apr. 2026
ROMÂNIA / COPII & JUNIORI: Nepoții lui Valeriu Irimescu au asistat la turneul de mini-rugby de pe stadionul Olimpia / VIDEO
Dedicată memoriei celui care a fost rugbystul de valoare mondială, iar apoi antrenorul de geniu Valeriu Irimescu (1940-2026), etapa cu numărul 3 din Campionatul de mini-rugby a Municipiului...
Newsletter GRATUIT
Aboneaza-te la newsletterul Rugby.ro si primeste ultimele noutati pe email.
